Condition: Developmental Verbal Dyspraxia · Autism Spectrum Disorder · Sponsor: MGH Institute of Health Professions
Comorbid Childhood Apraxia of Speech (CAS) may be one factor that limits speech development in some minimally verbal children with autism. CAS is a disorder affecting speech movement planning. This study tests whether CAS-specific treatment, appropriately modified for minimally verbal children with autism, improves their speech.
This description comes directly from the study's public registry record.
Karen V Chenausky, Ph.D. · 617-726-2405 · kvchenausky@mghihp.edu
Michael Moody · 617-643-4658 · mjmoody@partners.org
Always discuss trial participation with your own doctor first.
| MGH Institute of Health Professions | Boston, Massachusetts, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05066178